Last reviewed · How we verify

NCT03937817

Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants

Recruiting now Last updated 14 April 2026
What this trial tests

trial in Alpha and Beta Thalassemia in 300 participants. Currently enrolling.

Timeline
25 September 2019
Primary endpoint
31 March 2029
31 March 2029

Quick facts

Lead sponsorNational Institute of Allergy and Infectious Diseases (NIAID)
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment300
Start date25 September 2019
Primary completion31 March 2029
Estimated completion31 March 2029
Sites1 location across United States

Conditions studied

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Who can join

Adults 18 to 70, any sex, with Alpha and Beta Thalassemia or Sickle Cell Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Blood disorders like sickle cell disease and malaria affect many people around the world. Researchers want to learn more about blood disorders. To do this, they need to collect biological samples from people with blood disorders. They also need to collect samples from healthy people. Objective: To collect samples to use for research on blood disorders. Eligibility: People ages 18-70 who have blood disorders. Healthy volunteers without blood disorders are also needed. Design: Participants will be screened with a medical history, physical exam, and blood and urine tests. Participants will give one or more samples. They will give them over 5 years. They can choose not to give any of the samples: Saliva: Participants will spit into a tube. They may also have the inside of their mouth swabbed. Urine: Participants will urinate into a cup. Blood and blood waste products: Blood will be taken through a needle in the participant s arm. Fat samples: An area on the participant s belly or buttock will be numbed. A small cut will be made into the skin and a small piece of fat removed. Mucus and cells from the lungs: The participant will be sedated. A flexible tube will be inserted through the nose or mouth into the lung airways. These participants will also have a physical exam, chest x-ray, and heart tests after the procedure. ...

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Sickle Trait and Alpha Thalassemia Increase NOS-Dependent Vasodilation of Human Arteries Through Disruption of Endothelial Hemoglobin-eNOS Interactions.
    Brooks SD, Ruhl AP, Zeng X, Cruz P, et al · · 2025 · cited 3× · PMID 39633569 · DOI 10.1161/circulationaha.123.066003
  2. Magnitude and variability of blood pressure and renal vascular conductance responses to postural changes, exercise, and cold in black adults: A pilot study.
    Ibrahim MH, McLure AJ, Jackson MJ, Harrison B, et al · · 2026 · PMID 42087563 · DOI 10.14814/phy2.70888

Verify or expand the search:

Other National Institute of Allergy and Infectious Diseases (NIAID) trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03937817.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing